The inhibitory role of si-UBB delivered by degradable dendrimers-based lipid nanoparticles in ovarian cancer.Published in:Cancer Nanotechnology (1868-6958), 2022, v. 11, n. 1, p. 1, doi. 10.1186/s12645-022-00112-3By:Shu, Shanrong;Liu, Xiaoping;Xu, Ming;Lin, Yaduan;Li, RuimanPublication type:Article
Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma.Published in:Cancer Nanotechnology (1868-6958), 2022, v. 11, n. 1, p. 1, doi. 10.1186/s12645-022-00111-4By:Yue, Huan;Gou, Luxia;Tang, Zhenrong;Liu, Yuyang;Liu, Shengchun;Tang, HuaPublication type:Article